A detailed history of Vanguard Group Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,654,482 shares of KPTI stock, worth $6.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,654,482
Previous 8,338,401 8.2%
Holding current value
$6.51 Million
Previous $12.6 Million 47.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.87 - $1.58 $595,009 - $1.08 Million
-683,919 Reduced 8.2%
7,654,482 $6.66 Million
Q1 2024

May 10, 2024

SELL
$0.72 - $1.66 $267,665 - $617,116
-371,757 Reduced 4.27%
8,338,401 $12.6 Million
Q4 2023

Feb 14, 2024

SELL
$0.68 - $1.31 $74,644 - $143,800
-109,771 Reduced 1.24%
8,710,158 $7.49 Million
Q3 2023

Nov 14, 2023

BUY
$1.14 - $1.81 $154,813 - $245,799
135,801 Added 1.56%
8,819,929 $11.8 Million
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $2.11 Million - $5.42 Million
1,180,292 Added 15.73%
8,684,128 $15.5 Million
Q1 2023

May 15, 2023

BUY
$2.84 - $3.92 $6.55 Million - $9.04 Million
2,306,334 Added 44.37%
7,503,836 $29.2 Million
Q4 2022

Feb 10, 2023

BUY
$2.48 - $5.93 $952,575 - $2.28 Million
384,103 Added 7.98%
5,197,502 $17.7 Million
Q3 2022

Nov 14, 2022

BUY
$4.08 - $5.82 $2.41 Million - $3.44 Million
591,419 Added 14.01%
4,813,399 $26.3 Million
Q2 2022

Aug 12, 2022

BUY
$4.15 - $8.37 $1.08 Million - $2.19 Million
261,272 Added 6.6%
4,221,980 $19 Million
Q1 2022

May 13, 2022

BUY
$5.91 - $14.38 $3.56 Million - $8.66 Million
601,901 Added 17.92%
3,960,708 $29.2 Million
Q4 2021

Feb 14, 2022

SELL
$5.21 - $8.61 $1.48 Million - $2.44 Million
-283,892 Reduced 7.79%
3,358,807 $21.6 Million
Q3 2021

Nov 12, 2021

BUY
$4.45 - $10.63 $130,665 - $312,128
29,363 Added 0.81%
3,642,699 $21.2 Million
Q2 2021

Aug 13, 2021

BUY
$8.11 - $11.11 $29.3 Million - $40.1 Million
3,613,336 New
3,613,336 $37.3 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67.8M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.